Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Technology in Cancer Research & Treatment|November 11, 2021
MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell CarcinomaFeng Du, Dezuo Dong, Xiaodong Zhang, et al.
Cancer Communications (London, England)|August 4, 2021
MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinomaQingnan Wu, Weimin Zhang, Yan Wang, et al.
Frontiers in Oncology|November 5, 2019
Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular InvasionYuting Zhao, Xianggao Zhu, Hongzhi Wang, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective StudySixuan Li, Dezuo Dong, Xuan Zheng, et al.
BMC Cancer|July 15, 2022
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinomaHongzhi Wang, Xianggao Zhu, Yuting Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Camrelizumab, a patinib and radiotherapy in locally advanced, unresectable hepatocellular carcinoma: a phase 2 studyHongzhi Wang, Kun Wang, Xuan Zheng, et al.
Annals of Translational Medicine|January 13, 2021
Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population studyDezuo Dong, Dan Zhao, Shuai Li, et al.
Cancer Research|December 16, 2020
A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma ProgressionDezuo Dong, Weimin Zhang, Wenchang Xiao, et al.
Journal of Medical Imaging and Radiation Oncology|March 4, 2022
Prognostic significance of albumin-bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapyDezuo Dong, Xianggao Zhu, Hongzhi Wang, et al.
Frontiers in Oncology|November 5, 2019
Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal CancerShuai Li, Dezuo Dong, Jianhao Geng, et al.
Pageof 2